Analysts predict that Nuvectra Corporation (NASDAQ:NVTR) will report earnings of ($1.27) per share for the current quarter, according to Zacks Investment Research. Zero analysts have issued estimates for Nuvectra Corporation’s earnings. Nuvectra Corporation also reported earnings of ($1.27) per share in the same quarter last year. The firm is expected to announce its next earnings report on Tuesday, March 6th.

According to Zacks, analysts expect that Nuvectra Corporation will report full-year earnings of ($4.77) per share for the current financial year. For the next financial year, analysts forecast that the company will report earnings of ($4.12) per share. Zacks Investment Research’s EPS calculations are an average based on a survey of sell-side research firms that cover Nuvectra Corporation.

Nuvectra Corporation (NASDAQ:NVTR) last posted its earnings results on Wednesday, November 1st. The company reported ($1.09) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($1.16) by $0.07. The company had revenue of $7.60 million for the quarter, compared to analysts’ expectations of $8.08 million. Nuvectra Corporation had a negative return on equity of 68.63% and a negative net margin of 204.19%. Nuvectra Corporation’s quarterly revenue was up 100.0% on a year-over-year basis. During the same period last year, the firm earned ($0.92) earnings per share.

Several research firms recently issued reports on NVTR. ValuEngine cut Nuvectra Corporation from a “hold” rating to a “sell” rating in a research note on Monday, October 2nd. Piper Jaffray Companies reissued a “hold” rating and issued a $12.00 target price on shares of Nuvectra Corporation in a research note on Friday, November 3rd. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and one has given a buy rating to the company’s stock. Nuvectra Corporation currently has an average rating of “Hold” and an average target price of $12.00.

Nuvectra Corporation (NVTR) traded up $0.08 during midday trading on Tuesday, hitting $8.61. The company had a trading volume of 23,800 shares, compared to its average volume of 58,753. The company has a current ratio of 2.90, a quick ratio of 2.72 and a debt-to-equity ratio of 0.37. Nuvectra Corporation has a 12 month low of $4.90 and a 12 month high of $15.00.

TRADEMARK VIOLATION WARNING: “Zacks: Brokerages Anticipate Nuvectra Corporation (NVTR) Will Post Earnings of -$1.27 Per Share” was first posted by American Banking News and is the sole property of of American Banking News. If you are viewing this piece of content on another domain, it was copied illegally and reposted in violation of United States and international trademark & copyright laws. The correct version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/11/21/zacks-brokerages-anticipate-nuvectra-corporation-nvtr-will-post-earnings-of-1-27-per-share.html.

Several hedge funds have recently added to or reduced their stakes in the company. Gilder Gagnon Howe & Co. LLC raised its holdings in Nuvectra Corporation by 4.5% in the 3rd quarter. Gilder Gagnon Howe & Co. LLC now owns 996,557 shares of the company’s stock worth $13,214,000 after acquiring an additional 43,126 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in Nuvectra Corporation by 4.0% in the 3rd quarter. Dimensional Fund Advisors LP now owns 730,117 shares of the company’s stock worth $9,681,000 after acquiring an additional 28,268 shares during the last quarter. Vanguard Group Inc. raised its holdings in Nuvectra Corporation by 6.2% in the 2nd quarter. Vanguard Group Inc. now owns 310,794 shares of the company’s stock worth $4,128,000 after acquiring an additional 18,081 shares during the last quarter. Hodges Capital Management Inc. raised its holdings in Nuvectra Corporation by 18.6% in the 2nd quarter. Hodges Capital Management Inc. now owns 227,807 shares of the company’s stock worth $3,025,000 after acquiring an additional 35,706 shares during the last quarter. Finally, Essex Investment Management Co. LLC raised its holdings in Nuvectra Corporation by 42.1% in the 2nd quarter. Essex Investment Management Co. LLC now owns 202,623 shares of the company’s stock worth $2,691,000 after acquiring an additional 60,034 shares during the last quarter. Hedge funds and other institutional investors own 56.30% of the company’s stock.

Nuvectra Corporation Company Profile

Nuvectra Corporation is a neurostimulation company that focuses on helping physicians to improve the lives of people with chronic neurological conditions. The Company’s Algovita Spinal Cord Stimulation (SCS) System (Algovita) is the Company’s commercial offering and is Conformite Europeene (CE) marked and the United States Food and Drug Administration (FDA) approved for the treatment of chronic pain of the trunk and/or limbs.

Get a free copy of the Zacks research report on Nuvectra Corporation (NVTR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Nuvectra Corporation (NASDAQ:NVTR)

Receive News & Ratings for Nuvectra Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuvectra Corporation and related companies with MarketBeat.com's FREE daily email newsletter.